The use of cryopreserved lymphocytes in the leukocyte adherence inhibition assay. I. Evaluation of specificity of responses in cancer patients

1978 ◽  
Vol 21 (5) ◽  
pp. 542-551 ◽  
Author(s):  
Stephen R. Waldman ◽  
Robert H. Yonemoto
Keyword(s):  
Cancer Patients ◽  
Leukocyte Adherence ◽  
Inhibition Assay ◽  
Leukocyte Adherence Inhibition ◽  
Adherence Inhibition

Leukocyte Adherence Inhibition Assay in the Diagnosis and Follow-Up of Colorectal Cancer Patients

Oncology ◽  
1986 ◽  
Vol 43 (1) ◽  
pp. 23-26 ◽  
Author(s):  
Z. Weisman ◽  
A. Shani ◽  
A. Fink ◽  
A. Shindel ◽  
A. Sela ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Patients ◽  
Leukocyte Adherence ◽  
Inhibition Assay ◽  
Leukocyte Adherence Inhibition ◽  
Colorectal Cancer Patients ◽  
Adherence Inhibition

The Lai Test in Specific Immune-Reactivity Studies of Fibrocystic Breast Disease

1982 ◽  
Vol 68 (4) ◽  
pp. 291-294
Author(s):  
Giorgio Cavallini ◽  
Gilberte Berti
Keyword(s):  
Skeletal Muscle ◽  
Gastric Carcinoma ◽  
Breast Disease ◽  
Immune Reactivity ◽  
Leukocyte Adherence ◽  
Inhibition Assay ◽  
Fibrocystic Disease ◽  
Fibrocystic Breast Disease ◽  
Leukocyte Adherence Inhibition ◽  
Adherence Inhibition

Sixteen cases of fibrocystic breast disease at different histopathologic stage were examined with the leukocyte adherence inhibition assay. Skeletal muscle and gastric carcinoma extracts were used as controls. The glass adherence of leukocytes from patients affected by fibrocystic breast disease was more inhibited when extracts from breasts with fibrocystic disease were used rather than control extracts. Nonadherence indexes (NAIs) were high in 8 cases, around 20 in 4 cases, a little above zero in 2 cases and below zero in 2 cases. NAIs were related to the histopathologic stage: the highest NAIs were found in 8 cases of classic fibrocystic disease, the lowest in 1 case of simple breast fibrosis.

Sign in / Sign up

Export Citation Format

Share Document